St. Jude Snags FDA Approval for First MultiPoint Pacing Technology

The FDA gave St. Jude Medical its blessing with the approval of its first-moving MultiPoint pacing technology. The new technology may offer an additional option to patients who do not respond to other therapies.

The new technology is featured on the Quadra Assura MP cardiac resynchronization therapy defibrillator, the Quadra Allure MP CRT-pacemaker and two new quadripolar Quartet LV leads.

Multipoint is designed to improve CRT response and capture more ventricular tissue quickly, according to the company. — Anisa Jibrell